期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

JAK信号通路与抗肿瘤治疗 被引量：2

下载PDF
导出
摘要 近年来，大量的研究表明，Janus激酶（JAK）信号通路不仅在胚胎的生长发育和造血中具有重要的作用，而且该通路的异常活化与多种肿瘤的发生发展密切相关。针对JAK信号通路的抗肿瘤研究已经成为一个全新的研究方向。本文就近年来针对JAK信号通路及其抑制物在抗肿瘤治疗中的相关研究进展进行综述。
作者 王凤梅(综述) 姚军(审校)
机构地区 台州学院椒江校区医学院医学检验系
出处 《检验医学与临床》 CAS 2012年第5期589-591,共3页 Laboratory Medicine and Clinic
基金 国家自然科学基金资助项目(No.81001113) 浙江省教育厅科研计划项目(No.Y201016160)
关键词 JANUS激酶 肿瘤 受体
分类号 R730.5 [医药卫生—肿瘤]
  • 相关文献

参考文献27

  • 1Quintás-Cardama A,Kantarjian H,Cortes J,et al.Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond[J].Nat Rev Drug Discov,2011,10(2):127-140.
  • 2Ghoreschi K,Laurence A,O′Shea JJ.Janus kinases in immune cell signaling[J].Immunol Rev,2009,228(1):273-287.
  • 3Lai SY,Johnson FM.Defining the role of the JAK-STAT pathway in head and neck and thoracic malignancies:implications for future therapeutic approaches[J].Drug Resist Updat,2010,13(3):67-78.
  • 4Tozawa H,Kanki Y,Suehiro J,et al.Genome-wide approaches reveal functional interleukin-4-inducible STAT6 binding to the vascular cell adhesion molecule 1 promoter[J].Mol Cell Biol,2011,31(11):2196-2209.
  • 5Kim YS,Choi SJ,Choi JP,et al.IL-12-STAT4-IFN-gamma axis is a key downstream pathway in the development of IL-13-mediated asthma phenotypes in a Th2 type asthma model[J].Exp Mol Med,2010,42(8):533-546.
  • 6Yu H,Pardoll D,Jove R.STATs in cancer inflammation and immunity:a leading role for STAT3[J].Nat Rev Cancer,2009,9(11):798-809.
  • 7Carlisi D,D′Anneo A,Angileri L,et al.Parthenolide sensitizes hepatocellular carcinoma cells to TRAIL by inducing the expression of death receptors through inhibition of STAT3 activation[J].J Cell Physiol,2011,226(6):1632-1641.
  • 8Agrawal S,Gollapudi S,Su H,et al.Leptin activates human B cells to secrete TNF-α,IL-6,and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway[J].J Clin Immunol,2011,31(3):472-478.
  • 9Starsíchová A,Lincová E,Pernicová Z,et al.TGF-beta1 suppresses IL-6-induced STAT3 activation through regulation of Jak2 expression in prostate epithelial cells[J].Cell Signal,2010,22(11):1734-1744.
  • 10Levine RL,Pardanani A,Tefferi A,et al.Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders[J].Nat Rev Cancer,2007,7(9):673-683.

二级参考文献65

  • 1Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants [ J ]. Biochim Biophys Acta, 1976,455 ( 1 ) : 152 - 162.
  • 2Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer:role of ATP-dependent transporters [ J ]. Nat Rev Cancer,2002,2( 1 ) :48 -58.
  • 3Abbott BL. ABCG2 (BCRP) expression in normal and malignant hematopoietic cells [J]. Hematol Oncol,2003, 21 (3) :115 - 130.
  • 4Scheffer GL, Schroeijers AB, Izquierdo MA, et al. Lung resistance-related protein/major vault protein and vaults in multidrug-resistant cancer [ J ]. Gurr Opin Oncol, 2000,12 (6) :550 - 556.
  • 5Amaudeau C, Lundin C, Helleday T. DNA double-strand breaks associated with replication forks are predominantly repaired by homologous recombination involving an exchange mechanism in mammalian cells [ J]. J Mol Biol, 2001,307(5) :1235 - 1245.
  • 6Sharma RA, Dianov GL. Targeting base excision repair to improve cancer therapies [J]. Mol Aspects Med ,2007 ,28 (3-4) :345 - 374.
  • 7Sedgwlck B. Repairing DNA-methylation damage [ J]. Nat Rev Mol Cell Bio,2004,5(2) :148 -157.
  • 8Chaney SG,Sancar A. DNA repair:enzymatic mechanisms and relevance to drag response [ J ]. J Natl Cancer Inst, 1996,88(19) :1346 - 1360.
  • 9Rosell R, Lord R V, Taron M, et al. DNA repair and cisplatin resistance in non-small-cell lung cancer [ J]. Lung Cancer,2002,38 (3) :217 - 227.
  • 10Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases [ J ]. Annu Rev Pharmacol Toxicol,2005,45 (5) :1 -88.

共引文献9

同被引文献22

  • 1Kim DH, Xu W, Ma C, et al. Genetic variants in the candi- date genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia[J]. Blood, 2019,113 ( 11 ) : 2517- 2525.
  • 2Kohroki J, Nishiyama T, Nakamura T, et al. ASB proteins interact with Cullin5 and Rbx2 to form E3 ubiquitin ligase complexes[J-]. FEBS Lett,2005,579(30) :6796-6802.
  • 3Xie S,Wang Y, Liu J,et al. Involvement of Jak2 tyrosine phosphorylation in Bcr-Abl transformation[J]. Oncogene,2001,20(43):6188-6195.
  • 4Kohroki J, Fujita S, Itoh N, et al. ATRA-regulated Asb-2 gene induced in differentiation of HL-60 leukemia cells[J]. FEBS Lett,2001,505(2) :223-228.
  • 5Guibal FC, Moog-Lutz C, Srnolewski P, et al. ASB-2 in- hibits growth and promotes commitment in myeloid leu- kemia cells[J]. J Biol Chem,2002,277(1) :218-224.
  • 6Heuze ML,Guibal FC,Banks CA,et al. ASB2 is an Elon- gin BC-interacting protein that can assemble with Cullin 5 and Rbxl to reconstitute an E3 ubiquitin ligase complex [J]. J Biol Chem,2005,280 (7) : 5468-5474.
  • 7McDaneld TG, Spurlock DM. Ankyrin repeat and sup- pressor of cytokine signaling(SOCS) boxcontaining pro- tein(ASB) 15 alters differentiation of mouse C2C12 myo blasts and phosphorylation of mitogen-aetivated protein kinase and Akt[J]. J Anim Sci,2008,86(11):2897 2902.
  • 8Wells JA,de Vos AM. Hematopoietic receptor complexes [J]. Annu Rev Biochem, 1996,65 (1) : 609-634.
  • 9Warsch W, Walz C, Sexl V. JAK of all trades: JAK2 STAT5 as novel therapeutic targets in BCR-ABL11 chro nic myeloid leukemia [J]- Blood, 2013, 122 ( 13 ) : 2167 2175.
  • 10Nosaka T, van Deursen JM, Tripp RA, et al. Defective lymphoid development in mice lacking J ak3[J]. Science, 1995,270(5237) : 800-802.

引证文献2

检验医学与临床
2012年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部